Product Description

[Drug Name]Clindamycin phosphate Gel

[Properties]This product is almost colorless and transparent gel.

[Ingredients]This product each containing clindamycin phosphate 0.1grams.Accessories as follows:carbomer,triethanolamine,preservatives(propylene glycol,isopropyl clcohol).

[Category]this product is the role of dermatology drugs drug class of non-prscription drugs.

[Indications]For the treatment of acne vulgaris.

[Specifications]1%.

[Usage and dosage]

Topical application,wash affected area with warm water,gently dried,the amout taken in the affected area coated a thin layer of gel,and 1 times a day sooner or later.

[Adverse reactions]

Dry skin ,local stimulation,rash and other allergic reactions.Occasional gastrointestinal discomfort and diarrhea.

 [Taboo]

Taboo has a history of colon or ulcerative colitis were banned.

[Notes]

1.    This product is partially absorted,it may cause diarrhea,at this time should be discontinued immediately to the physician consultation.

2.    Do not place this product for other bacterial skin infections.

3.    Avoid contact with eyes and other mucous menbranes(such as the mouth,nose,etc.).If the mistake into the eye should be thoroghly washed with water.

4.    Drug site where burning sensation,itching,swelling,etc.should be discontinued,and local drug clean,if necessary,consule the doctor.

5.    Pergnant with caution,must be used,such as breast-feeding women should be breast-feeding.

6.    Children under the age of *2 should use under the guidance of the physician.

7.    For those who are allergic to the product is disabled,allergic caution.

8.    Do not use when this product properties change.

9.    This product must be placed where children can not catch.

*0. Children use it under the guaidance of the physician.

[Storage]sealed,in the shade(no more than*0℃) to save.

[Packaging]composite plastic tube packaging , *0g /piece / box&*0g / piece / box.

[Validity]*4months

[Executive standard]WS*-(X***0)****3Z

[Approval number]country medicine accurate H*******8

[Specification revision date]Mar.*0.***7